Skip to content

A prospective study to explore the effect on work productivity when strengthening exercise therapy in patients with chronic low back pain

Open-label, randomized, parallel group trial to evaluate the effect on work productivity by patient education and strengthening exercise therapy in patients with chronic low back pain - Open-label, randomized, parallel group trial to evaluate the effect on work productivity by patient education and strengthening exercise therapy in patients with chronic low back pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041037
Enrollment
100
Registered
2020-07-09
Start date
2020-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic low back pain

Interventions

Strengthening exercise therapy group Non-strengthening exercise therapy group

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who have low back pain more than three months 2. Ages 20 to 64 3. Patients who have medications for low back pain. 4. Patients who have ability to walk without assistance 5. Patients who will work more than three days a week 6. Patients who have ability to use of mobile communication devices

Exclusion criteria

Exclusion criteria: 1. Patients who have the Red flags 2. Patient who are pregnant or wish to become pregnant 3. Patients who have radiculopathy 4. Patients who have strong opioids

Design outcomes

Primary

MeasureTime frame
The changes of work productivity (QQ method)

Secondary

MeasureTime frame
1) the changes of work productivity (WPAI:GH) 2) the changes of low back pain level (NRS), stiff shoulders level and improvement in self evaluations of low back pain and stiff shoulders 3) the change of QoL (specific low back pain QoL:RDQ-24, health-related QoL:EQ-5D-5L) 4) the changes of fear-avoidance beliefs (TSK-11) 5) the changes of depression level (K-6) 6) the changes of the drug doses 7) the change ratio of visiting medical institutions

Countries

Japan

Contacts

Public ContactHiroichi Yamamoto

Mebix, Inc. Research promotion division

hiroichi.yamamoto@mebix.co.jp03-4362-4504

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026